Status:

COMPLETED

Propofol-related Euphoria in Pain-free Gastrointestinal Endoscopy Patients

Lead Sponsor:

Northern Jiangsu People's Hospital

Conditions:

Propofol

Addictive Behaviors

Eligibility:

All Genders

18-80 years

Brief Summary

To define the prevalence, duration and severity of propofol-associated euphoria in patients undergoing painless gastrointestinal endoscopy and to explore the independent influencing factors by means o...

Eligibility Criteria

Inclusion

  • Proposed to perform painless GI endoscopy, and simple endoscopic maneuvers such as single small polyp clamping, performing HP examination, etc;
  • Gender is not limited;
  • 18 years old ≤ 80 years old;
  • ASA classification: I-II;
  • 18 kg/m2 \<BMI \<30 kg/m2;
  • Informed consent, voluntary participation in the trial, and informed consent signed by the subjects themselves.

Exclusion

  • adjudicated respiratory management difficulties;
  • History of substance abuse as well as drug use;
  • Participation in a clinical trial of another drug or device within 3 months prior to the screening period
  • Use of therapeutic drugs (e.g., benzodiazepines, opioid analgesics) by the subject within 3 months prior to the Screening Period for a variety of reasons (e.g., insomnia, pain, etc.) that may have an impact on the outcome of the trial, etc;
  • Allergy or contraindication to the study drug or components thereof;
  • Previous psychiatric or neurological disorders (e.g., schizophrenia, mania, bipolar disorder, psychosis, epilepsy, neuralgia, etc.) and a history of taking medications corresponding to the treatment of the corresponding psychiatric or neurological disorders (e.g., antidepressants, anxiolytics, convulsants, antiepileptic drugs, etc.);
  • Pregnant women;
  • Subjects with severe communication disorders due to severe hearing deterioration;
  • Refusal to participate in this study;
  • Those deemed unsuitable by the investigator.

Key Trial Info

Start Date :

September 18 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 30 2025

Estimated Enrollment :

986 Patients enrolled

Trial Details

Trial ID

NCT06602297

Start Date

September 18 2024

End Date

June 30 2025

Last Update

December 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northern Jiangsu People's Hospital

Yangzhou, Jiangsu, China, 225001